Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.